Biotech · Private company
CicloMed LLC
Track this companyFree. Adds CicloMed LLC to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- CPX-POMPhase 2 · Bladder CancerClinicalTrials.gov · fetched Nov 12, 2026
- FosciclopiroxPhase 2 · Refractory Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- Fosciclopirox + CytarabinePhase 2 · Refractory Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POMPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 120 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 240 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 30 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 360 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 60 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- CPX-POM - 600 mg/m^2Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of Fosciclopirox in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPHASE1_PHASE2 · TERMINATED · started Aug 27, 2021ClinicalTrials.gov NCT04956042 · fetched Nov 12, 2026
- Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder TumorsPHASE2 · COMPLETED · started Nov 25, 2020ClinicalTrials.gov NCT04525131 · fetched Nov 12, 2026
- Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started May 19, 2019ClinicalTrials.gov NCT04608045 · fetched Nov 12, 2026
- Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Jan 15, 2018ClinicalTrials.gov NCT03348514 · fetched Nov 12, 2026